Treatment of Mycoplasma Hominis and Ureaplasma Urealyticum in Pregnant Women
Journal: International Journal of Science and Research (IJSR) (Vol.9, No. 6)Publication Date: 2020-06-05
Authors : Daniela Tasha; Ilir Tasha; Nikita Manoku;
Page : 1385-1387
Keywords : Women; Ureaplasma spp Mycoplasma hominis; Antimicrobial susceptibility;
Abstract
The purpose of this study is to ivestigate the antimicrobial suspectability and resistance patterns of genital mycoplasma in pregnant women attending antenatal care. The antimicrobial suspectability testing included tetracycline, doxycycline, erythromycin, azithromycin, clarithromycin, josamycin, ofloxacin, ciprofloxacin, and pristinamycin. The development or absence of red color on the relevant part of the strip provided an index of resistance or susceptibility to each antimicrobial agent, respectively, according to the guidelines of the CLSI. To maintain a safety pregnancy, it is important to identify the isolates and use the appropriate antibiotics immediately. Early pregnancy screening for genital mycoplasmas and following treatment may reduce preterm deliveries.
Other Latest Articles
- Performance Evaluation of Diesel Engine Fueled with Jatropha Methyl Ester Blends along with Sunflower Oil
- Artificial Intelligence in the Control of Food Borne Diseases: A Review
- Plight of Factory Workers during the Time of COVID-19 Lockdown: A Review
- Millennial Work Force: Opportunities and Challenges
- Stress among Nurses, Causes and Impact on their Performance
Last modified: 2021-06-28 17:08:00